BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10511409)

  • 1. Activity of moxifloxacin against mycobacteria.
    Gillespie SH; Billington O
    J Antimicrob Chemother; 1999 Sep; 44(3):393-5. PubMed ID: 10511409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents].
    Duan HF; Doi N; Li Q; Ma Y; Chen XY; Fu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 May; 33(5):359-62. PubMed ID: 20646615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of four fluoroquinolones against Mycobacterium tuberculosis.
    Rodríguez JC; Ruiz M; Climent A; Royo G
    Int J Antimicrob Agents; 2001 Mar; 17(3):229-31. PubMed ID: 11282270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro antimycobacterial activity of a new quinolone, NM394].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Aug; 68(8):517-20. PubMed ID: 8397311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis.
    Chan CY; Au-Yeang C; Yew WW; Leung CC; Cheng AF
    Antimicrob Agents Chemother; 2004 Jan; 48(1):340-3. PubMed ID: 14693563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis.
    Rodríguez JC; Ruiz M; López M; Royo G
    Int J Antimicrob Agents; 2002 Dec; 20(6):464-7. PubMed ID: 12458143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent killing of antibiotic-resistant pneumococci by the methoxyquinolone moxifloxacin.
    Klugman KP; Capper T
    J Antimicrob Chemother; 1997 Dec; 40(6):797-802. PubMed ID: 9462430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.
    Gillespie SH; Morrissey I; Everett D
    J Med Microbiol; 2001 Jun; 50(6):565-570. PubMed ID: 11393294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin sensitivity of respiratory pathogens in the United Kingdom.
    Dorai-John T; Thomson CJ; Amyes SG
    J Chemother; 2002 Feb; 14(1):19-24. PubMed ID: 11892894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus.
    Al-Nawas B; Shah PM
    J Antimicrob Chemother; 1998 Jun; 41(6):655-8. PubMed ID: 9687105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria.
    Ackermann G; Schaumann R; Pless B; Claros MC; Goldstein EJ; Rodloff AC
    Eur J Clin Microbiol Infect Dis; 2000 Mar; 19(3):228-32. PubMed ID: 10795599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of the new quinolone moxifloxacin (Bay 12-8039) against resistant gram-positive clinical isolates.
    Alcalá L; Cercenado E; García-Garrote F; Bouza E
    Diagn Microbiol Infect Dis; 1999 Jan; 33(1):27-31. PubMed ID: 9990472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.
    Ji B; Lounis N; Maslo C; Truffot-Pernot C; Bonnafous P; Grosset J
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2066-9. PubMed ID: 9687408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative susceptibility to penicillin and quinolones of 1385 Streptococcus pneumoniae isolates. Austrian Bacterial Surveillance Network.
    Buxbaum A; Straschil U; Moser C; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1999 May; 43 Suppl B():13-8. PubMed ID: 10382870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of new fluoroquinolones and linezolid against non-tuberculous mycobacteria.
    Rodriguez Díaz JC; López M; Ruiz M; Royo G
    Int J Antimicrob Agents; 2003 Jun; 21(6):585-8. PubMed ID: 12791475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.
    Alvirez-Freites EJ; Carter JL; Cynamon MH
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1022-5. PubMed ID: 11897584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial activity of moxifloxacin, gatifloxacin and six fluoroquinolones against Streptococcus pneumoniae.
    Saravolatz L; Manzor O; Check C; Pawlak J; Belian B
    J Antimicrob Chemother; 2001 Jun; 47(6):875-7. PubMed ID: 11389122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone.
    Fass RJ
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1818-24. PubMed ID: 9257770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.